> Research Triangle Park, NC-based Metabolon has settled a patent dispute with Stemina Biomarker Discovery over its technology. The two companies resolved the dispute by forging a licensing deal. Story
> Cancer experts are critical of Canada's "patchwork" system for testing patients for genetic markers that will flag the likelihood of responding to new drugs. Story